Fig. 4: Clinical course and treatment timeline for Patient No. 4.

dMMR mismatch repair proteins deficiency, G3 grade 3, IHC immunohistochemistry, ICT Department of Investigational Cancer Therapeutics, mo months, NED no evidence of disease. Prostate-specific antigen (PSA) reference range ≤4 ng/mL.